Alexandria Real Estate Equities reported a net loss per share of $0.96 and FFO per share, as adjusted, of $2.05 for the first quarter of 2022. The company continued to experience strong leasing volume and internal growth.
Total revenues reached $615.1 million, a 28.2% increase year-over-year.
The company executed long-term leases, including 426,927 RSF with Bristol-Myers Squibb and 333,929 RSF with Eli Lilly and Company.
Net operating income (cash basis) annualized reached $1.5 billion, up 24.9% compared to 1Q21 annualized.
Liquidity stood at $5.7 billion as of March 31, 2022.
The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2022.
Analyze how earnings announcements historically affect stock price performance